A study supported the ellipsoid zone loss as a meaningful biomarker that can be used to guide clinical trial design in ...
Mean vision gains of +9 letters among patients with extensive coverage of OpRegen cell therapy to the Geographic Atrophy (GA) lesion site Evidence of retinal structural improvement persisted out to 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback